REGN
REGN
NASDAQ · Biotechnology

Regeneron Pharmaceuticals

S&P 500 Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks
$749.47
+7.78 (+1.05%)
As of Mar 25, 9:32 PM ET ·
Analyst Consensus
Strong Buy
36
Analysts
Very High
Coverage
Buy 27 75%
Hold 9 25%
Sell 0 0%
Price Target
Analyst Price Target -89.8% upside
Low Target $61.79
Average Target $76.80
High Target $111.17
Current Price $749.47
Current
$749.47
Target
$76.80
$61.79 $76.80 avg $111.17
Scenario Analysis
Bear Case
$61.79
-91.8%
Low target
Base Case
$76.80
-89.8%
Avg target
Bull Case
$111.17
+-85.2%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$821.11
-8.7% from high
52-Week Low
$476.49
+57.3% from low
50-Day SMA
$763.91
-1.9% vs SMA
200-Day SMA
$631.14
+18.7% vs SMA
RSI (14)
59.8
Neutral
Target vs 52W High
$76.80
-90.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%